Background More than 10 years have elapsed since human papillomavirus (HPV)
vaccination was implemented. We did a systematic review and meta-analysis of the …

The discovery of genotype 16 as the prototype oncogenic human papillomavirus (HPV)
initiated a quarter century of laboratory and epidemiological studies that demonstrated their …

HPV is the cause of almost all cervical cancer and is responsible for a substantial fraction of
other anogenital cancers and oropharyngeal cancers. Understanding the HPV‐attributable …

Summary Background On Sept 1, 2008, Scotland launched routine vaccination for human
papillomavirus (HPV) types 16 and 18, targeted at 12–13-year-old girls, of whom 92· 4 …

Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause
of several cancers, including cervical cancer, and genital warts. Although cervical cancer …

Cervical cancer screening will rely, increasingly, on HPV testing as a primary screen. The
requirement for triage tests which can delineate clinically significant infection is thus …

Human papillomavirus (HPV) vaccines work by preventing infections prior to natural
exposure. Thus, it is likely more effective at younger ages, and it is important to understand …

Background Human papillomavirus (HPV) vaccine was recommended in 2006 for routine
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …

The World Health Organization estimates that global vaccination programs save 2 to 3
million lives per year by priming the immune system to protect against pathogenic threats …

(1) Introduction: A Romanian woman is diagnosed with cervical cancer every two hours; the
country ranks second in Europe in terms of the mortality and incidence rate of this disease …